Lonza to manufacture Intellect Neurosciences drug; Scammers go after Internet drug buyers;

> India has put new price controls on nearly 350 drugs, up from the 74 that had limits. Story

> Drugmakers are now owed between $15.4 billion and $19.5 billion by European countries that have yet to pay their pharma bills. Story

> Intellect Neurosciences plans to have Lonza manufacture its new antibody-drug conjugate Conjumab-A. Item

> Indian API maker Cadila Pharmaceutical says one of its employees working with its pharmaceutical division has been arrested for embezzlement. Story

> While the diabetes drug metformin holds potential as a cheap and effective treatment against some cancers, drugmakers are reluctant to invest in research for a drug already off patent. Story

And Finally... The FDA is investigating reports that scammers are calling people who have purchased drugs from Internet pharmacies and threatening them if they don't pay fines. Story

Suggested Articles

Neopharma, which has been buying and building plants for several years, is buying a sterile injectables plant and assets in Japan from India’s Lupin. 

Already knocked by the FDA four times this year, Dr. Reddy’s now has a fifth Form 483 to dwell on. This time it’s at a plant with a history of faults.

In a warning letter, the FDA details how a Chinese OTC drugmaker handed over documents faked just for the agency's inspection—and admitted it.